Peripheral Vascular Stents Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

Peripheral Vascular Stents Pipeline Market Report Overview

A peripheral vascular stent is an expandable perforated tube that is inserted into a peripheral vessel to prevent blood flow constriction. The peripheral vascular stents pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated with the trials.

Key Segments ·       Peripheral Bioabsorbable Stents

·       Peripheral Drug-Eluting Stents

·       Iliac Artery Stents

·       Tracheobronchial Stents

·       Peripheral Bare Metal Stents

·       Peripheral Covered Stents

Key Territories ·       The US

·       China

·       Europe

·       Japan

·       India

Key Regulatory Paths ·       PMA

·       CE

·       NMPA

·       Shonin

·       510(k)

Leading Companies ·       3D Biotek LLC

·       Abbott Vascular Inc

·       Acotec Scientific Holdings Ltd

·       amg International GmbH

·       AndraTec GmbH

Enquire & Decide Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.

Peripheral Vascular Stents Pipeline Market by Segments

The key segments of the peripheral vascular stents pipeline market are peripheral bioabsorbable stents, peripheral drug-eluting stents, iliac artery stents, tracheobronchial stents, peripheral bare metal stents, and peripheral covered stents. As of September 2024, peripheral bioabsorbable stents accounted for the highest share of pipeline products.

Peripheral Vascular Stents Pipeline Market Analysis by Segments, 2024 (%)

Peripheral Vascular Stents Pipeline Market Analysis by Segments, 2024 (%)

Buy the Full Report for More Segment Insights into the Peripheral Vascular Stents Pipeline Market

Download a Free Report Sample

Peripheral Vascular Stents Pipeline Market Segmentation by Territories

A few of the key territories with the peripheral vascular stents pipeline market are the US, China, Europe, Japan, and India. As of September 2024, the US accounted for the highest number of pipeline products.

Peripheral Vascular Stents Pipeline Market Analysis by Territories, 2024 (%)

Peripheral Vascular Stents Pipeline Market Analysis by Territories, 2024 (%)

Buy the Full Report for More Territory Insights into the Peripheral Vascular Stents Pipeline Market

Download a Free Report Sample

Peripheral Vascular Stents Pipeline Market Segmentation by Regulatory Paths

A few of the key regulatory paths in the peripheral vascular stents pipeline products market are PMA, CE, NMPA, Shonin, and 510(k). As of September 2024, PMA was the most followed pathway for pipeline products in the peripheral vascular stents market.

Peripheral Vascular Stents Pipeline Market Analysis by Regulatory Paths, 2024 (%)

Peripheral Vascular Stents Pipeline Market Analysis by Regulatory Paths, 2024 (%)

Buy the Full Report for More Regulatory Path Insights into the Peripheral Vascular Stents Pipeline Market

Download a Free Report Sample

Peripheral Vascular Stents Pipeline Market – Competitive Landscape

A few of the key companies associated with the peripheral vascular stents pipeline market are 3D Biotek LLC, Abbott Vascular Inc., Acotec Scientific Holdings Ltd, amg International GmbH, and AndraTec GmbH, among others.

Abbott Vascular Inc.: Headquartered in Santa Clara, California, the US, it is a medical device company that develops, manufactures, and markets cardiovascular devices. The company offers coronary intervention, peripheral intervention, and structural heart products. Its coronary intervention products include bleedback control valves, coronary dilatation catheters, coronary drug-eluting stents, coronary guide wires, and others. Abbott Vascular’s peripheral intervention products comprise peripheral guide wires, dilatation catheters, guiding catheters, and stent-grafts. The company provides minimally invasive treatment for mitral regurgitation and other structural defects of the heart. It also offers education and training services for healthcare professionals.

amg International GmbH: Headquartered in Winsen, Germany, it is a medical device company that develops, manufactures, and markets stents, stent implantation systems, balloon catheters, and other auxiliary products. It provides coronary vascular intervention products and peripheral vascular intervention products. The company’s peripheral vascular interventional products include thalis inert balloon-expandable stent, FACILE self-expendable peripheral stent-implantation system, and Allunga PTA balloon.

Peripheral Vascular Stents Pipeline Market Analysis by Companies, 2024

Peripheral Vascular Stents Pipeline Market Analysis by Companies, 2024

Buy the Full Report for More Company Insights into the Peripheral Vascular Stents Pipeline Market

Download a Free Report Sample

Segments Covered in the Report

Peripheral Vascular Stents Pipeline Market Segments Outlook (2024)

  • Peripheral Bioabsorbable Stents
  • Peripheral Drug Eluting Stents
  • Iliac Artery Stents
  • Tracheobronchial Stent

Peripheral Vascular Stents Pipeline Market Territories Outlook (2024)

  • The US
  • China
  • Europe
  • Japan
  • India

Peripheral Vascular Stents Pipeline Market Regulatory Paths Outlook (2024)

  • PMA
  • CE
  • NMPA
  • Shonin
  • 510(k)

Scope

This report provides:

  • Extensive coverage of the peripheral vascular stents under development.
  • An exhaustive list of major pipeline products and their details, including product description, licensing and collaboration details, and other developmental activities.
  • Reviews of major players involved in the development of peripheral vascular stents and lists all their pipeline projects.
  • Coverage of pipeline products based on various stages of development ranging from early development to approved/issued stage.
  • Key clinical trial data of ongoing clinical trials specific to pipeline products.
  • Recent developments in the segment/industry.

Reasons to Buy

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies.
  • Identify emerging players with potentially strong product portfolios and create effective counter strategies to gain a competitive advantage.
  • Identify and understand important and diverse types of peripheral vascular stents under development.
  • Develop market-entry and market-expansion strategies.
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline.
  • Carry out an in-depth analysis of the product’s current stage of development, territory, and estimated launch date.

3D Biotek LLC
Abbott Vascular Inc
Acotec Scientific Holdings Ltd
amg International GmbH
AndraTec GmbH
Arterius Ltd
Becton Dickinson and Co
Biotyx Medical (Shenzhen) Co Ltd
Boston Scientific Corp
Cook Medical Inc
Cordis US Corp
CorInnova, Inc.
Cytograft Tissue Engineering Inc (Inactive)
Efemoral Medical LLC
Efferent Labs Inc
Electroformed Stents Inc
Elixir Medical Corp
Endomimetics LLC
FIT Biotech Oy (Inactive)
HeMo Bioengineering Ltd
ID Nest Medical SAS
InspireMD Inc
Intressa Vascular SA
Kyoto Medical Planning Co Ltd
LeoMed, LLC
Lepu Medical Technology (Beijing) Co Ltd
LimFlow SA
Lyra Therapeutics Inc
Meril Life Sciences Pvt Ltd
Micell Technologies Inc
Micro Medical Solutions Inc
Natec Medical Ltd
Nipro Corp
NSVascular, Inc.
OrbusNeich
PeriTec Biosciences Ltd
QualiMed Innovative Medizinprodukte GmbH
Qvanteq AG
Reflow Medical, Inc.
Shanghai Bio-heart Biological Technology Co Ltd
Shanghai Easy-Flow Medical Tech Co Ltd
Shanghai MicroPort Endovascular MedTech Group Co Ltd
Shenzhen Salubris Pharmaceuticals Co Ltd
Suzhou Fengzhi Medical Technology Co Ltd
Suzhou Yinluo Medical Devices Co Ltd
Synergy Flow Ltd
Tepha Inc
Terumo Corp
TissueGen Inc
Tractivus SL
University of Michigan
University of Pittsburgh
University of Pittsburgh Medical Center
Vascular Bioresorbable Technologies
Vascular Concepts Ltd
Vesper Medical Inc
VINNOVA
VueKlar Cardiovascular Ltd (Inactive)
Wake Forest University Health Sciences
Xenogenics Corporation
Zorion Medical
Zylox-Tonbridge Medical Technology Co Ltd

Table of Contents

|1 Table of Contents

|1.1 List of Tables

|1.2 List of Figures

2 Introduction

2.1 Peripheral Vascular Stents Overview

3 Products under Development

3.1 Peripheral Vascular Stents – Pipeline Products by Stage of Development

3.2 Peripheral Vascular Stents – Pipeline Products by Segment

3.3 Peripheral Vascular Stents – Pipeline Products by Territory

3.4 Peripheral Vascular Stents – Pipeline Products by Regulatory Path

3.5 Peripheral Vascular Stents – Pipeline Products by Estimated Approval Date

3.6 Peripheral Vascular Stents – Ongoing Clinical Trials

4 Peripheral Vascular Stents – Pipeline Products under Development by Companies

4.1 Peripheral Vascular Stents Companies – Pipeline Products by Stage of Development

4.2 Peripheral Vascular Stents – Pipeline Products by Stage of Development

5 Peripheral Vascular Stents Companies and Product Overview

5.1 3D Biotek LLC Company Overview

5.1.1 3D Biotek LLC Pipeline Products & Ongoing Clinical Trials Overview

5.2 Abbott Vascular Inc Company Overview

5.2.1 Abbott Vascular Inc Pipeline Products & Ongoing Clinical Trials Overview

5.3 Acotec Scientific Holdings Ltd Company Overview

5.3.1 Acotec Scientific Holdings Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.4 amg International GmbH Company Overview

5.4.1 amg International GmbH Pipeline Products & Ongoing Clinical Trials Overview

5.5 AndraTec GmbH Company Overview

5.5.1 AndraTec GmbH Pipeline Products & Ongoing Clinical Trials Overview

5.6 Arterius Ltd Company Overview

5.6.1 Arterius Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.7 Becton Dickinson and Co Company Overview

5.7.1 Becton Dickinson and Co Pipeline Products & Ongoing Clinical Trials Overview

5.8 Biotyx Medical (Shenzhen) Co Ltd Company Overview

5.8.1 Biotyx Medical (Shenzhen) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.9 Boston Scientific Corp Company Overview

5.9.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview

5.10 Cook Medical Inc Company Overview

5.10.1 Cook Medical Inc Pipeline Products & Ongoing Clinical Trials Overview

5.11 Cordis US Corp Company Overview

5.11.1 Cordis US Corp Pipeline Products & Ongoing Clinical Trials Overview

5.12 CorInnova, Inc. Company Overview

5.12.1 CorInnova, Inc. Pipeline Products & Ongoing Clinical Trials Overview

5.13 Cytograft Tissue Engineering Inc (Inactive) Company Overview

5.13.1 Cytograft Tissue Engineering Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

5.14 Efemoral Medical LLC Company Overview

5.14.1 Efemoral Medical LLC Pipeline Products & Ongoing Clinical Trials Overview

5.15 Efferent Labs Inc Company Overview

5.15.1 Efferent Labs Inc Pipeline Products & Ongoing Clinical Trials Overview

5.16 Electroformed Stents Inc Company Overview

5.16.1 Electroformed Stents Inc Pipeline Products & Ongoing Clinical Trials Overview

5.17 Elixir Medical Corp Company Overview

5.17.1 Elixir Medical Corp Pipeline Products & Ongoing Clinical Trials Overview

5.18 Endomimetics LLC Company Overview

5.18.1 Endomimetics LLC Pipeline Products & Ongoing Clinical Trials Overview

5.19 FIT Biotech Oy (Inactive) Company Overview

5.19.1 FIT Biotech Oy (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

5.20 HeMo Bioengineering Ltd Company Overview

5.20.1 HeMo Bioengineering Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.21 ID Nest Medical SAS Company Overview

5.21.1 ID Nest Medical SAS Pipeline Products & Ongoing Clinical Trials Overview

5.22 InspireMD Inc Company Overview

5.22.1 InspireMD Inc Pipeline Products & Ongoing Clinical Trials Overview

5.23 Intressa Vascular SA Company Overview

5.23.1 Intressa Vascular SA Pipeline Products & Ongoing Clinical Trials Overview

5.24 Kyoto Medical Planning Co Ltd Company Overview

5.24.1 Kyoto Medical Planning Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.25 LeoMed, LLC Company Overview

5.25.1 LeoMed, LLC Pipeline Products & Ongoing Clinical Trials Overview

5.26 Lepu Medical Technology (Beijing) Co Ltd Company Overview

5.26.1 Lepu Medical Technology (Beijing) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.27 LimFlow SA Company Overview

5.27.1 LimFlow SA Pipeline Products & Ongoing Clinical Trials Overview

5.28 Lyra Therapeutics Inc Company Overview

5.28.1 Lyra Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview

5.29 Meril Life Sciences Pvt Ltd Company Overview

5.29.1 Meril Life Sciences Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.30 Micell Technologies Inc Company Overview

5.30.1 Micell Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview

5.31 Micro Medical Solutions Inc Company Overview

5.31.1 Micro Medical Solutions Inc Pipeline Products & Ongoing Clinical Trials Overview

5.32 Natec Medical Ltd Company Overview

5.32.1 Natec Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.33 Nipro Corp Company Overview

5.33.1 Nipro Corp Pipeline Products & Ongoing Clinical Trials Overview

5.34 NSVascular, Inc. Company Overview

5.34.1 NSVascular, Inc. Pipeline Products & Ongoing Clinical Trials Overview

5.35 OrbusNeich Company Overview

5.35.1 OrbusNeich Pipeline Products & Ongoing Clinical Trials Overview

5.36 PeriTec Biosciences Ltd Company Overview

5.36.1 PeriTec Biosciences Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.37 QualiMed Innovative Medizinprodukte GmbH Company Overview

5.37.1 QualiMed Innovative Medizinprodukte GmbH Pipeline Products & Ongoing Clinical Trials Overview

5.38 Qvanteq AG Company Overview

5.38.1 Qvanteq AG Pipeline Products & Ongoing Clinical Trials Overview

5.39 Reflow Medical, Inc. Company Overview

5.39.1 Reflow Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview

5.40 Shanghai Bio-heart Biological Technology Co Ltd Company Overview

5.40.1 Shanghai Bio-heart Biological Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.41 Shanghai Easy-Flow Medical Tech Co Ltd Company Overview

5.41.1 Shanghai Easy-Flow Medical Tech Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.42 Shanghai MicroPort Endovascular MedTech Group Co Ltd Company Overview

5.42.1 Shanghai MicroPort Endovascular MedTech Group Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.43 Shenzhen Salubris Pharmaceuticals Co Ltd Company Overview

5.43.1 Shenzhen Salubris Pharmaceuticals Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.44 Suzhou Fengzhi Medical Technology Co Ltd Company Overview

5.44.1 Suzhou Fengzhi Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.45 Suzhou Yinluo Medical Devices Co Ltd Company Overview

5.45.1 Suzhou Yinluo Medical Devices Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.46 Synergy Flow Ltd Company Overview

5.46.1 Synergy Flow Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.47 Tepha Inc Company Overview

5.47.1 Tepha Inc Pipeline Products & Ongoing Clinical Trials Overview

5.48 Terumo Corp Company Overview

5.48.1 Terumo Corp Pipeline Products & Ongoing Clinical Trials Overview

5.49 TissueGen Inc Company Overview

5.49.1 TissueGen Inc Pipeline Products & Ongoing Clinical Trials Overview

5.50 Tractivus SL Company Overview

5.50.1 Tractivus SL Pipeline Products & Ongoing Clinical Trials Overview

5.51 University of Michigan Company Overview

5.51.1 University of Michigan Pipeline Products & Ongoing Clinical Trials Overview

5.52 University of Pittsburgh Company Overview

5.52.1 University of Pittsburgh Pipeline Products & Ongoing Clinical Trials Overview

5.53 University of Pittsburgh Medical Center Company Overview

5.53.1 University of Pittsburgh Medical Center Pipeline Products & Ongoing Clinical Trials Overview

5.54 Vascular Bioresorbable Technologies Company Overview

5.54.1 Vascular Bioresorbable Technologies Pipeline Products & Ongoing Clinical Trials Overview

5.55 Vascular Concepts Ltd Company Overview

5.55.1 Vascular Concepts Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.56 Vesper Medical Inc Company Overview

5.56.1 Vesper Medical Inc Pipeline Products & Ongoing Clinical Trials Overview

5.57 VINNOVA Company Overview

5.57.1 VINNOVA Pipeline Products & Ongoing Clinical Trials Overview

5.58 VueKlar Cardiovascular Ltd (Inactive) Company Overview

5.58.1 VueKlar Cardiovascular Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

5.59 Wake Forest University Health Sciences Company Overview

5.59.1 Wake Forest University Health Sciences Pipeline Products & Ongoing Clinical Trials Overview

5.60 Xenogenics Corporation Company Overview

5.60.1 Xenogenics Corporation Pipeline Products & Ongoing Clinical Trials Overview

5.61 Zorion Medical Company Overview

5.61.1 Zorion Medical Pipeline Products & Ongoing Clinical Trials Overview

5.62 Zylox-Tonbridge Medical Technology Co Ltd Company Overview

5.62.1 Zylox-Tonbridge Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

6 Peripheral Vascular Stents- Recent Developments

6.1 Aug 27, 2024: Medtronic Chairman and CEO Geoff Martha to Speak at the Wells Fargo Healthcare Conference

6.2 Aug 27, 2024: Medtronic Chairman and CEO Geoff Martha to Speak at the Wells Fargo Healthcare Conference

6.3 Aug 26, 2024: Zylox-Tonbridge Reports Strong Interim Financial Results for 2024, Achieving Significant Growth and Profitability

6.4 Aug 01, 2024: Merit Medical Systems Announces Q2 2024 Results and Raises Full-Year Guidance

6.5 Jul 08, 2024: CONMED to Announce Second Quarter 2024 Financial Results on July 31, 2024

6.6 Jul 02, 2024: Reflow Medical enrols first subject for coronary treatment device study

6.7 Jun 27, 2024: Abbott Hosts Conference Call for Second-Quarter Earnings

6.8 Jun 18, 2024: Micro Medical Solutions Achieves Milestone with 200th Enrollment in HEAL Registry

6.9 Jun 18, 2024: Merit Medical Systems to Announce Second Quarter 2024 Results on August 1, 2024

6.10 Jun 13, 2024: First patient implanted with Philips’ Duo Venous stent system

6.11 Jun 13, 2024: Medtronic Confirms Global Layoffs

6.12 May 09, 2024: Reflow Medical Completes Enrollment in the Deeper Reveal Clinical Trial

6.13 May 08, 2024: Abbott Vascular obtains Pre-Market Approval For ESPRIT BTK Bioresorbable Vascular Scaffold System

6.14 Apr 12, 2024: Getinge secures EU MDR certification for Advanta V12 stent

6.15 Apr 09, 2024: Getinge iCast Covered Stent System Considered Medically Necessary for Treatment of Iliac Arterial Occlusive Disease

6.16 Mar 26, 2024: Getinge Enters into Commercial Distribution Agreement with Cook Medical for iCast Covered Stent System in the United States

6.17 Mar 12, 2024: Medtronic To Present At Barclays Global Healthcare Conference

6.18 Mar 04, 2024: BD Initiates International Study to Expand Treatment Options for Patients With Peripheral Arterial Disease

6.19 Feb 28, 2024: Boston Scientific Raises $2.2B to Support Purchase of California Medical Device Company

6.20 Feb 23, 2024: Edwards Lifesciences to Present at the 44th Annual TD Cowen Healthcare Conference

6.21 Feb 23, 2024: Medical Tech Leader, Boston Scientific (BSX), Announces Notes Offering

6.22 Feb 21, 2024: Zylox-Tonbridge Receives Marketing Approvals for Multiple Products in the Uae

6.23 Feb 15, 2024: Stephen Agostini Named UCLA’s Vice Chancellor and Chief Financial Officer

6.24 Jan 31, 2024: W. L. Gore & Associates Receives U.S. Food & Drug Administration (FDA) Approval for Lower Profile Gore Viabahn Vbx Balloon Expandable Endoprosthesis, Now 6 FR Sheath Compatible

6.25 Jan 16, 2024: Reflow Medical granted CE mark for Spur stent system

6.26 Jan 16, 2024: First Patients Enrolled in the Gore VBX Forward Clinical Study

6.27 Jan 05, 2024: Boston Scientific Announces Conference Call Discussing Fourth Quarter 2023 Results

6.28 Dec 20, 2023: Zylox-Tonbridge Medical : Voluntary Announcement Completion of Patient Enrollment for the Zenflex Peripheral Stent System Post-Marketing Clinical Trial in the European Union

6.29 Dec 06, 2023: Micro Medical Solutions Announces Completion of Enrollment in the STAND Pivotal Clinical Trial

6.30 Nov 16, 2023: Cordis Announces Enrollment Completion of the RADIANCY Clinical Study in Europe

6.31 Oct 31, 2023: First Round of Late-Breaking Clinical Trial Results Announced at VIVA23

6.32 Oct 31, 2023: Second Round of Late-Breaking Clinical Trial Results Announced at VIVA23

6.33 Oct 31, 2023: CONMED Corp. to Participate in Fireside Chats at Two Investor Conferences on November 14-15

6.34 Oct 30, 2023: Late-Breaking Clinical Trial Results Announced at The VEINS 2023

6.35 Oct 25, 2023: Late-Breaking Data Show Esprit BTK Drug-Eluting Resorbable Scaffold Reduces Chronic Limb-Threatening Ischemia Progression Compared to the Standard of Care

6.36 Oct 18, 2023: Edwards Lifesciences to Host Earnings Conference Call on October 25, 2023

6.37 Oct 02, 2023: LimFlow Obtains Pre-Market Approval (PMA) for LimFlow System

7 Appendix

7.1 Methodology

7.2 About GlobalData

7.3 Contact Us

7.4 Disclaimer

Table

Peripheral Vascular Stents – Pipeline Products by Stage of Development

Peripheral Vascular Stents – Pipeline Products by Segment

Peripheral Vascular Stents – Pipeline Products by Territory

Peripheral Vascular Stents – Pipeline Products by Regulatory Path

Peripheral Vascular Stents – Pipeline Products by Estimated Approval Date

Peripheral Vascular Stents – Ongoing Clinical Trials

Peripheral Vascular Stents Companies – Pipeline Products by Stage of Development

Peripheral Vascular Stents – Pipeline Products by Stage of Development

3D Biotek LLC Pipeline Products & Ongoing Clinical Trials Overview

Bioresorbable Drug Eluting Peripheral Polymer Stent – Product Status

Bioresorbable Drug Eluting Peripheral Polymer Stent – Product Description

Abbott Vascular Inc Pipeline Products & Ongoing Clinical Trials Overview

ESPRIT Bioresorbable Vascular Scaffold – Product Status

ESPRIT Bioresorbable Vascular Scaffold – Product Description

Acotec Scientific Holdings Ltd Pipeline Products & Ongoing Clinical Trials Overview

Peripheral Spot Stent – Product Status

Peripheral Spot Stent – Product Description

Spot Stent System – Product Status

Spot Stent System – Product Description

Acotec Scientific Holdings Ltd – Ongoing Clinical Trials Overview

Spot Stent System – A Prospective, Multicenter and Randomized Controlled Trial to Evaluate the Efficacy and Safety of a Spot Stent System Using in the Percutaneous Transluminal Angioplasty of Femoropopliteal Arteries

amg International GmbH Pipeline Products & Ongoing Clinical Trials Overview

UNITY-B Peripheral Stent – Product Status

UNITY-B Peripheral Stent – Product Description

AndraTec GmbH Pipeline Products & Ongoing Clinical Trials Overview

Pillar Bifurcation Reconstruction Device – Product Status

Pillar Bifurcation Reconstruction Device – Product Description

Arterius Ltd Pipeline Products & Ongoing Clinical Trials Overview

Bioresorbable Stent – Peripheral Vascular Disease – Product Status

Bioresorbable Stent – Peripheral Vascular Disease – Product Description

Becton Dickinson and Co Pipeline Products & Ongoing Clinical Trials Overview

BD Liverty TIPS Stent Graft – Product Status

BD Liverty TIPS Stent Graft – Product Description

BD Vascular Covered Stent – Product Status

BD Vascular Covered Stent – Product Description

Becton Dickinson and Co – Ongoing Clinical Trials Overview

BD Liverty TIPS Stent Graft – Liverty TIPS Stent Graft

BD Vascular Covered Stent – A Prospective, Multi-center, Non-randomized, Single-Arm Study of the BDTM Low Profile Vascular Covered Stent in Peripheral Artery Disease (AGILITY)

Biotyx Medical (Shenzhen) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

IBS Titan – Product Status

IBS Titan – Product Description

Biotyx Medical (Shenzhen) Co Ltd – Ongoing Clinical Trials Overview

IBS Titan – A Prospective, Multi-Center, Randomized Trial Comparing the IBS Titan Sirolimus-Eluting Iron Bioresorbable Peripheral Scaffold System vs. Standard Balloon Angioplasty for Treatment of Below-the-Knee Arteries: GENIUS TRIAL

IBS Titan – A Prospective, Multicentre, Single Arm Clinical Trial to Assess the Safety and Effectiveness of Sirolimus-eluting Iron Bioresorbable Peripheral Scaffold System (IBS Titan) in Treating Patients With Infrapopliteal Arterial Stenosis or Occlusive Disease

Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview

SAVAL Drug Eluting Stent BTK – Product Status

SAVAL Drug Eluting Stent BTK – Product Description

Symbiot Covered Stent System – Product Status

Symbiot Covered Stent System – Product Description

Wallstent RP Endoprosthesis – Venous Outflow Obstruction – Product Status

Wallstent RP Endoprosthesis – Venous Outflow Obstruction – Product Description

Boston Scientific Corp – Ongoing Clinical Trials Overview

Wallstent RP Endoprosthesis – Venous Outflow Obstruction – Sinai Vein Stent Registry

Cook Medical Inc Pipeline Products & Ongoing Clinical Trials Overview

Drug-Eluting Stent – Below The Knee – Product Status

Drug-Eluting Stent – Below The Knee – Product Description

Zenith Connection Endovascular Covered Stent – Product Status

Zenith Connection Endovascular Covered Stent – Product Description

Cook Medical Inc – Ongoing Clinical Trials Overview

Zenith Connection Endovascular Covered Stent – The Enzen Trial: Comparison of EVAR Outcomes With Endurant Versus Zenith Endoprosthesis: a Prospective Analysis.

Cordis US Corp Pipeline Products & Ongoing Clinical Trials Overview

FlexStent Self Expanding Below-The-Knee Venous Stent System – Product Status

FlexStent Self Expanding Below-The-Knee Venous Stent System – Product Description

FlexStent Self Expanding Venous Stent System – Product Status

FlexStent Self Expanding Venous Stent System – Product Description

S.M.A.R.T. RADIANZ Vascular Stent System – Product Status

S.M.A.R.T. RADIANZ Vascular Stent System – Product Description

Tibial SE FlexStent – Product Status

Tibial SE FlexStent – Product Description

CorInnova, Inc. Pipeline Products & Ongoing Clinical Trials Overview

Hybrid Dynamic Stent – Product Status

Hybrid Dynamic Stent – Product Description

Cytograft Tissue Engineering Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

LifeJacket Stent Graft – Peripheral – Product Status

LifeJacket Stent Graft – Peripheral – Product Description

Efemoral Medical LLC Pipeline Products & Ongoing Clinical Trials Overview

Efemoral Device – Product Status

Efemoral Device – Product Description

Efferent Labs Inc Pipeline Products & Ongoing Clinical Trials Overview

RTI-LICD Plexisense – Product Status

RTI-LICD Plexisense – Product Description

Electroformed Stents Inc Pipeline Products & Ongoing Clinical Trials Overview

Helical Stent – Product Status

Helical Stent – Product Description

Patch Stent – Product Status

Patch Stent – Product Description

Pleated Stent – Product Status

Pleated Stent – Product Description

Elixir Medical Corp Pipeline Products & Ongoing Clinical Trials Overview

PRAVA Bioresorbable Scaffold – Product Status

PRAVA Bioresorbable Scaffold – Product Description

Endomimetics LLC Pipeline Products & Ongoing Clinical Trials Overview

Peripheral Vascular Stent – Product Status

Peripheral Vascular Stent – Product Description

FIT Biotech Oy (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

GTU X-Stent – Product Status

GTU X-Stent – Product Description

GTU X2-Stent – Product Status

GTU X2-Stent – Product Description

HeMo Bioengineering Ltd Pipeline Products & Ongoing Clinical Trials Overview

Peripheral Drug Eluting Stent – Product Status

Peripheral Drug Eluting Stent – Product Description

ID Nest Medical SAS Pipeline Products & Ongoing Clinical Trials Overview

ID Venous System – Product Status

ID Venous System – Product Description

InspireMD Inc Pipeline Products & Ongoing Clinical Trials Overview

PVGuard Peripheral – Product Status

PVGuard Peripheral – Product Description

Intressa Vascular SA Pipeline Products & Ongoing Clinical Trials Overview

Cardiatis FluidSmart 3D Stent – Product Status

Cardiatis FluidSmart 3D Stent – Product Description

Kyoto Medical Planning Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

REMEDY – Drug Eluting – Product Status

REMEDY – Drug Eluting – Product Description

REMEDY – New Version – Product Status

REMEDY – New Version – Product Description

LeoMed, LLC Pipeline Products & Ongoing Clinical Trials Overview

Peripheral Arterial Stent – Product Status

Peripheral Arterial Stent – Product Description

Lepu Medical Technology (Beijing) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

Bare Stent – Product Status

Bare Stent – Product Description

LimFlow SA Pipeline Products & Ongoing Clinical Trials Overview

LimFlow Percutaneous Deep Vein Arterialisation System – Product Status

LimFlow Percutaneous Deep Vein Arterialisation System – Product Description

LimFlow SA – Ongoing Clinical Trials Overview

LimFlow Percutaneous Deep Vein Arterialisation System – Natural Progression of High-Risk Chronic Limb-Threatening Ischemia: The CLariTI Study

LimFlow Percutaneous Deep Vein Arterialisation System – Percutaneous Deep Vein Arterialization for the Treatment of Late-stage Chronic Limb-threatening Ischemia: The PROMISE II Trial

LimFlow Percutaneous Deep Vein Arterialisation System – Percutaneous Deep Vein Arterialization for the Treatment of Late-Stage Chronic Limb-Threatening Ischemia: The PROMISE III Trial

LimFlow Percutaneous Deep Vein Arterialisation System – Percutaneous Deep Vein Arterialization Post-market Study

LimFlow Percutaneous Deep Vein Arterialisation System – Percutaneous Deep Vein Arterialization Post-market Study

Lyra Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview

Stanza Bioresorbable Pediatric Scaffold – Product Status

Stanza Bioresorbable Pediatric Scaffold – Product Description

Stanza Bioresorbable Self-Expanding Scaffold – Product Status

Stanza Bioresorbable Self-Expanding Scaffold – Product Description

Meril Life Sciences Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview

Interlace BRS – Product Status

Interlace BRS – Product Description

Melange BRS – Product Status

Melange BRS – Product Description

Meril Life Sciences Pvt Ltd – Ongoing Clinical Trials Overview

Melange BRS – A Prospective, Multicentre, Open Label Clinical Study to Evaluate Safety and Performance of Melange BRS Sirolimus Eluting Bioresorbable Peripheral Scaffold System for Use as an Adjunct to Percutaneous Transluminal Renal Angioplasty of Atherosclerotic De Novo or Restenotic Lesion of the Renal Artery

Micell Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview

Peripheral Drug-Eluting Stent – Product Status

Peripheral Drug-Eluting Stent – Product Description

Micro Medical Solutions Inc Pipeline Products & Ongoing Clinical Trials Overview

MicroStent – Product Status

MicroStent – Product Description

Micro Medical Solutions Inc – Ongoing Clinical Trials Overview

MicroStent – A Clinical Evaluation of the MicroStent Peripheral Vascular Stent in Subjects with Arterial Disease below the Knee: STAND

MicroStent – An All-comers Observational Study of the MicroStent Peripheral Vascular Stent System in Subjects with Peripheral Arterial Disease

Natec Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview

Marina – Product Status

Marina – Product Description

Nipro Corp Pipeline Products & Ongoing Clinical Trials Overview

Peripheral Stent – Product Status

Peripheral Stent – Product Description

NSVascular, Inc. Pipeline Products & Ongoing Clinical Trials Overview

Micropatterned TFN Stent – Product Status

Micropatterned TFN Stent – Product Description

OrbusNeich Pipeline Products & Ongoing Clinical Trials Overview

Self-Expandable PTA Stent – Product Status

Self-Expandable PTA Stent – Product Description

Small Vessel – BTA – Product Status

Small Vessel – BTA – Product Description

PeriTec Biosciences Ltd Pipeline Products & Ongoing Clinical Trials Overview

Periteneum-Lined Balloon-Expandable Stent – Product Status

Periteneum-Lined Balloon-Expandable Stent – Product Description

Peritoneum Lined Self-Expanding Stent – Product Status

Peritoneum Lined Self-Expanding Stent – Product Description

QualiMed Innovative Medizinprodukte GmbH Pipeline Products & Ongoing Clinical Trials Overview

SOZO With 0.014″ PERSEUS-q PTA Balloon Catheter – Product Status

SOZO With 0.014″ PERSEUS-q PTA Balloon Catheter – Product Description

Tracheobronchial Stent – Product Status

Tracheobronchial Stent – Product Description

Qvanteq AG Pipeline Products & Ongoing Clinical Trials Overview

Qstent Peripheral Stent – Product Status

Qstent Peripheral Stent – Product Description

Reflow Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview

Bare Temporary Spur Stent System – Product Status

Bare Temporary Spur Stent System – Product Description

Reflow Medical, Inc. – Ongoing Clinical Trials Overview

Bare Temporary Spur Stent System – A Non-randomized Trial of the Temporary Spur Stent System for the Treatment of Lesions Located in the Infrapopliteal Arteries Outside of the United States

Bare Temporary Spur Stent System – A Prospective Single-Arm Multicenter Study of the Bare Temporary Spur Stent System for the Treatment of Vascular Lesions Located in the Infrapopliteal Arteries Below the Knee (DEEPER REVEAL)

Bare Temporary Spur Stent System – A Randomized Controlled Trial of the Drug Eluting Temporary Spur Stent System Vs Percutaneous Balloon Angioplasty for the Treatment of Critical Limb Ischemia

Bare Temporary Spur Stent System – Pilot Study of the Coronary Spur Stent for In-stent Restenosis (DEEPER CORONARY)

Shanghai Bio-heart Biological Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

Bio-Leap Below-The-Knee (BTK) BRS System – Product Status

Bio-Leap Below-The-Knee (BTK) BRS System – Product Description

Shanghai Easy-Flow Medical Tech Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

Cardiac Stent – Arteriovenous Fistula – Product Status

Cardiac Stent – Arteriovenous Fistula – Product Description

Cardiac Stent – Deep Vein Thrombosis – Product Status

Cardiac Stent – Deep Vein Thrombosis – Product Description

Cardiac Stent – Peripheral Arterial Stenosis – Product Status

Cardiac Stent – Peripheral Arterial Stenosis – Product Description

Cardiac Stent – Varicose Veins – Product Status

Cardiac Stent – Varicose Veins – Product Description

Shanghai MicroPort Endovascular MedTech Group Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

Venous Stent – Product Status

Venous Stent – Product Description

Shenzhen Salubris Pharmaceuticals Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

GSTREAM Rapamycin Drug-Eluting Peripheral Vascular Stent – Product Status

GSTREAM Rapamycin Drug-Eluting Peripheral Vascular Stent – Product Description

Iliac Vein Stent – Product Status

Iliac Vein Stent – Product Description

Lower Limb Arterial Drug-Loaded Stent – Product Status

Lower Limb Arterial Drug-Loaded Stent – Product Description

Peripheral Vascular Stent – Product Status

Peripheral Vascular Stent – Product Description

Shenzhen Salubris Pharmaceuticals Co Ltd – Ongoing Clinical Trials Overview

GSTREAM Rapamycin Drug-Eluting Peripheral Vascular Stent – A Multicenter, Randomized, Controlled, Superiority Clinical Trial to Evaluate the Safety and Efficacy of Drug-eluting Peripheral Arterial Stent System(G-stream) in the Treatment of the Above-the-knee Femoropopliteal Artery Stenosis or Occlusion

Suzhou Fengzhi Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

Sperstent – Product Status

Sperstent – Product Description

Suzhou Fengzhi Medical Technology Co Ltd – Ongoing Clinical Trials Overview

Sperstent – A Prospective, Multicenter and Randomized Controlled Trial to Evaluate the Efficacy and Safety of Sperstent Peripheral Spot Stent System Used for the Residual Lesions after Percutaneous Transluminal Angioplasty of Femoropopliteal Arteries

Suzhou Yinluo Medical Devices Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

Iliac Vein Stent – Product Status

Iliac Vein Stent – Product Description

Synergy Flow Ltd Pipeline Products & Ongoing Clinical Trials Overview

ArtiStent – Product Status

ArtiStent – Product Description

Tepha Inc Pipeline Products & Ongoing Clinical Trials Overview

TephaFLEX Fully Absorbable Peripheral Stent – Product Status

TephaFLEX Fully Absorbable Peripheral Stent – Product Description

Terumo Corp Pipeline Products & Ongoing Clinical Trials Overview

MISAGO RX Self-Expanding Stent System – Product Status

MISAGO RX Self-Expanding Stent System – Product Description

Terumo Corp – Ongoing Clinical Trials Overview

MISAGO RX Self-Expanding Stent System – Occlusive/Stenotic Peripheral Artery Revascularization Study for Common And/Or External ILIAC Artery using the Misago Rx Self-expanding Peripheral Stent:OSPREY ILIAC

TissueGen Inc Pipeline Products & Ongoing Clinical Trials Overview

Archer Stent – Product Status

Archer Stent – Product Description

Tractivus SL Pipeline Products & Ongoing Clinical Trials Overview

Bacteriophobic Tracheal Stent – Product Status

Bacteriophobic Tracheal Stent – Product Description

University of Michigan Pipeline Products & Ongoing Clinical Trials Overview

Tracheal Stent – Product Status

Tracheal Stent – Product Description

University of Pittsburgh Pipeline Products & Ongoing Clinical Trials Overview

Dual Chamber Stent – Product Status

Dual Chamber Stent – Product Description

University of Pittsburgh Medical Center Pipeline Products & Ongoing Clinical Trials Overview

Retrievable Vascular Stent – Product Status

Retrievable Vascular Stent – Product Description

Vascular Bioresorbable Technologies Pipeline Products & Ongoing Clinical Trials Overview

Drug Eluting Scaffold – Peripheral Artery Disease – Product Status

Drug Eluting Scaffold – Peripheral Artery Disease – Product Description

Drug Free Pure Bioresorbable Scaffold – Peripheral Artery Disease – Product Status

Drug Free Pure Bioresorbable Scaffold – Peripheral Artery Disease – Product Description

Vascular Concepts Ltd Pipeline Products & Ongoing Clinical Trials Overview

Covered Peripheral Stent – Product Status

Covered Peripheral Stent – Product Description

Prograft SX – Product Status

Prograft SX – Product Description

Vesper Medical Inc Pipeline Products & Ongoing Clinical Trials Overview

Vesper Duo Venous Stent System – Product Status

Vesper Duo Venous Stent System – Product Description

Vesper Medical Inc – Ongoing Clinical Trials Overview

Vesper Duo Venous Stent System – Prospective, Single-centre Post-Market Clinical Follow-up (PMCF) Study to Evaluate Safety and Performance of the DUO Venous Stent

Vesper Duo Venous Stent System – Venous Stent for the Iliofemoral Vein Investigational Clinical Trial Using the DUO Venous Stent System

VINNOVA Pipeline Products & Ongoing Clinical Trials Overview

Grency Venous Stent System – Product Status

Grency Venous Stent System – Product Description

VueKlar Cardiovascular Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

MR-Enhancing Balloon Expandable Stent – Product Status

MR-Enhancing Balloon Expandable Stent – Product Description

MR-Enhancing Self-Expanding Stent – Product Status

MR-Enhancing Self-Expanding Stent – Product Description

Wake Forest University Health Sciences Pipeline Products & Ongoing Clinical Trials Overview

Vascular Stent – Product Status

Vascular Stent – Product Description

Xenogenics Corporation Pipeline Products & Ongoing Clinical Trials Overview

Ideal BioStent – Peripheral – Product Status

Ideal BioStent – Peripheral – Product Description

Unison Peripheral Stent System – Product Status

Unison Peripheral Stent System – Product Description

Zorion Medical Pipeline Products & Ongoing Clinical Trials Overview

ZMED Absorbable Drug Eluting Stent – Product Status

ZMED Absorbable Drug Eluting Stent – Product Description

Zylox-Tonbridge Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

Multi-Spot Stent System – Product Status

Multi-Spot Stent System – Product Description

ZENFLEX Pinto Spot Stent System – Product Status

ZENFLEX Pinto Spot Stent System – Product Description

ZENFLEX Pro Peripheral Drug Eluting Stent System – Product Status

ZENFLEX Pro Peripheral Drug Eluting Stent System – Product Description

Zylox-Tonbridge Medical Technology Co Ltd – Ongoing Clinical Trials Overview

ZENFLEX Pro Peripheral Drug Eluting Stent System – Swedish Drug-elution Trial in Peripheral Arterial Disease – A Multicenter, Prospective Randomized Controlled Clinical Trial Based on the Swedish Vascular Registry (SWEDVASC) Platform

ZENFLEX Pinto Spot Stent System – A Prospective, Multicenter, Randomized Controlled Trail Using Spot Stenting to Treat Lower Extremity Post-angioplasty Dissection

Glossary

Figures

Peripheral Vascular Stents – Pipeline Products by Stage of Development

Peripheral Vascular Stents – Pipeline Products by Segment

Peripheral Vascular Stents – Pipeline Products by Territory

Peripheral Vascular Stents – Pipeline Products by Regulatory Path

Peripheral Vascular Stents – Pipeline Products by Estimated Approval Date

Peripheral Vascular Stents – Ongoing Clinical Trials

Frequently asked questions

Peripheral Vascular Stents Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies standard reports
Currency USD
$4,000

Can be used by individual purchaser only

$12,000

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Download FREE Resources

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Sample Report

Peripheral Vascular Stents Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Peripheral Vascular Stents Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies in real time.

  • Access a live Peripheral Vascular Stents Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.